BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23991715)

  • 1. The influence of acute renal injury on arginine and methylarginines metabolism.
    Sukhovershin RA; Gilinsky MA
    Ren Fail; 2013; 35(10):1404-11. PubMed ID: 23991715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of asymmetric dimethylarginine in the regulation of nitric oxide level in rats with acute renal injury].
    Sukhovershin RA; Gilinskiĭ MA
    Ross Fiziol Zh Im I M Sechenova; 2012 Apr; 98(4):497-505. PubMed ID: 22834339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney.
    Tojo A; Welch WJ; Bremer V; Kimoto M; Kimura K; Omata M; Ogawa T; Vallance P; Wilcox CS
    Kidney Int; 1997 Dec; 52(6):1593-601. PubMed ID: 9407505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined ratios of L-arginine and asymmetric and symmetric dimethylarginine as biomarkers in spontaneously hypertensive rats.
    Hsu CN; Huang LT; Lau YT; Lin CY; Tain YL
    Transl Res; 2012 Feb; 159(2):90-8. PubMed ID: 22243793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine, endothelial dysfunction and renal disease.
    Aldámiz-Echevarría L; Andrade F
    Int J Mol Sci; 2012; 13(9):11288-11311. PubMed ID: 23109853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Second Life of Methylarginines as Cardiovascular Targets.
    Jarzebska N; Mangoni AA; Martens-Lobenhoffer J; Bode-Böger SM; Rodionov RN
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The methylarginines NMMA, ADMA, and SDMA are ubiquitous constituents of the main vegetables of human nutrition.
    Servillo L; Giovane A; Cautela D; Castaldo D; Balestrieri ML
    Nitric Oxide; 2013 Apr; 30():43-8. PubMed ID: 23438481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic oral L-arginine administration on the L-arginine/NO pathway in patients with peripheral arterial occlusive disease or coronary artery disease: L-Arginine prevents renal loss of nitrite, the major NO reservoir.
    Schneider JY; Rothmann S; Schröder F; Langen J; Lücke T; Mariotti F; Huneau JF; Frölich JC; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1961-74. PubMed ID: 26123989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethylarginine-dimethylaminohydrolase-2 (DDAH-2) does not metabolize methylarginines.
    Altmann KS; Havemeyer A; Beitz E; Clement B
    Chembiochem; 2012 Nov; 13(17):2599-604. PubMed ID: 23125090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DdaR (PA1196) Regulates Expression of Dimethylarginine Dimethylaminohydrolase for the Metabolism of Methylarginines in Pseudomonas aeruginosa PAO1.
    Lundgren BR; Bailey FJ; Moley G; Nomura CT
    J Bacteriol; 2017 Apr; 199(8):. PubMed ID: 28167521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia.
    Nijveldt RJ; Teerlink T; van Guldener C; Prins HA; van Lambalgen AA; Stehouwer CD; Rauwerda JA; van Leeuwen PA
    Nephrol Dial Transplant; 2003 Dec; 18(12):2542-50. PubMed ID: 14605276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous regulators of NO bioavailability in rats with acute renal failure.
    Sukhovershin RA; Gilinsky MA
    Bull Exp Biol Med; 2012 Aug; 153(4):444-7. PubMed ID: 22977840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension.
    Okubo K; Hayashi K; Wakino S; Matsuda H; Kubota E; Honda M; Tokuyama H; Yamamoto T; Kajiya F; Saruta T
    Hypertens Res; 2005 Feb; 28(2):181-9. PubMed ID: 16025746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Biliary Levels of Arginine and its Methylated Derivatives after Hepatic Ischaemia/Reperfusion.
    Ferrigno A; Di Pasqua LG; Berardo C; Rizzo V; Richelmi P; Vairetti M
    Basic Clin Pharmacol Toxicol; 2016 Jul; 119(1):101-9. PubMed ID: 26663642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA).
    Nijveldt RJ; Teerlink T; Siroen MP; van Lambalgen AA; Rauwerda JA; van Leeuwen PA
    Clin Nutr; 2003 Feb; 22(1):17-22. PubMed ID: 12553945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human liver clears both asymmetric and symmetric dimethylarginine.
    Siroen MP; van der Sijp JR; Teerlink T; van Schaik C; Nijveldt RJ; van Leeuwen PA
    Hepatology; 2005 Mar; 41(3):559-65. PubMed ID: 15726655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases.
    Zakrzewicz D; Eickelberg O
    BMC Pulm Med; 2009 Jan; 9():5. PubMed ID: 19178698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.